The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2019-20.
The purpose of this document is to inform researchers undertaking NLRDs about the Gene Technology Regulator’s (the Regulator’s) operational policy for considering requests to conduct NLRDs in alternate facilities, pursuant to regulation 13(2)(c).
This document provides guidance to licence holders/applicants on the OGTR’s policy in relation to licensing for commercial release1 of genetically modified (GM) plants produced by conventional breeding (‘stacking’) between different, separately licensed, plant genetically modified organisms (GMOs).
This document provides guidance to DIR licence holders and applicants on crops that may be grown during the post harvest monitoring period after field trials. Currently this advice is limited to field trials of GM brassica (Brassica napus, Brassica juncea) and GM cotton.
The national legislative scheme for gene technology comprises the Gene Technology Act 2000, the Gene Technology Regulations 2001 and corresponding state and territory legislation.
Licence holders who wish to make an application for a transfer should contact the OGTR for details on how to apply.
Certification holders should contact the OGTR for details on how to apply for variation.
This document provides information on the scope of changes which may be made to a genetically modified organism (GMO) licence after the licence has been issued, and outlines the Gene Technology Regulator’s (the Regulator’s) approach to considering applications to vary conditions of a GMO licence.
This guidance document assists Institutional Biosafety Committees (IBCs) with assessing NLRD proposals involving dealings with retroviral vectors able to transduce human cells.
This guidance note indicates the minimum information that must accompany any request to modify a certification, such as a variation, suspension, lift of suspension, surrender and transfer.